Tests an automated insulin pump system in adults with type 1 diabetes
Tests an automated insulin delivery patch pump in adults with type 1 diabetes.
Plain-language title generated from the registry record
Registry title: Efficacy and Safety of the APGO Algorithm for Automated Insulin Delivery
Key facts
- Where
- Prague, CzechiaSee the site
Where in Czechia
- 3rd Department of Internal Medicine, 1st Faculty of Medicine, Charles University, Prague, CzechiaPrague, CzechiaTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Charles University, Czech Republic
- Trial code
- NCT07320495
- Record updated
- 6 January 2026
- Original description
The Medtrum TouchCare Nano system with the APGO algorithm is the only patch pump-based automated insulin delivery system available in the Czech Republic. However, until now, no prospective clinical study has evaluated its efficacy and safety under real-world conditions. The RENEW study is the first to address this topic.Read full original descriptionShow less
Efficacy and Safety of the APGO Algorithm for Automated Insulin Delivery: The RENEW Study
The Medtrum TouchCare Nano system with the APGO algorithm is the only patch pump-based automated insulin delivery system available in the Czech Republic. However, until now, no prospective clinical study has evaluated its efficacy and safety under real-world conditions. The RENEW study is the first to address this topic.
Inclusion: patients with T1D; type 1 diabetes for ≥1 years; ≥ 18 years old; written informed consent prior to starting study related activity.
Exclusion: use of medication with effects on carbohydrate metabolism; severe noncompliance; lactation, pregnancy, intending to become pregnant during study.